Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:00:43.079Z.
Calculation as of: 2026-10-06T16:00:43.079Z.
Quote observation: 2026-10-06T15:52:41.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ca6b3f945453907090b614e1109f6f6fce8b12406cb587c45253d0481e46e17d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Aligos Therapeutics, Inc.
Market Cap
$33.93M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$34.56M
Operating Cash Flow Yield
N/A
TTM Avg
13.07%
3Y Avg
8.54%
5Y Avg
8.65%
Market Cap
$34.58M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$32.76M
Operating Cash Flow Yield
N/A
TTM Avg
0.20%
3Y Avg
0.20%
5Y Avg
0.20%
Market Cap
$35.62M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$32.14M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.76M
Operating Cash Flow Yield
N/A
TTM Avg
53.98%
3Y Avg
44.70%
5Y Avg
26.51%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | $33.93M | N/A | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $34.56M | N/A | 13.07% | 8.54% | 8.65% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.58M | N/A | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $32.76M | N/A | 0.20% | 0.20% | 0.20% |
| Elutia Inc (ELUT)vs › | $35.42M | N/A | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $32.32M | N/A | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.62M | N/A | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.14M | N/A | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $35.76M | N/A | 53.98% | 44.70% | 26.51% |
| Rockwell Medical, Inc. (RMTI)vs › | $31.93M | 9.07% | 9.56% | 8.42% | 8.42% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
